🇺🇸 FDA
Pipeline program

[14C]IDV184001AN

INDV-2000-105

Phase 1 small_molecule completed

Quick answer

[14C]IDV184001AN for Opioid Use Disorder is a Phase 1 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid Use Disorder
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials